Abstract

Abstract The enantiomeric composition of ibuprofen in plasma has been investigated following the oral administration of the racemic drug in a novel controlled release (CR) formulation to healthy subjects. The plasma concentration-time profiles suggest that drug release from the CR preparation was suitably modified and that the fluctuation between the peaks and troughs observed following a conventional tablet formulation were reduced. The plasma concentrations of ( S )-ibuprofen were greater than those of the ( R )-enantiomer following either formulation, and the enantiomeric plasma ratio (S/R) was reduced, both in magnitude and variability, following the CR preparation. The proportion of the total area under the plasma concentration-time curves, due to ( S )-ibuprofen were slightly reduced following the CR formulation compared to the tablet formulation. The importance of a consideration of stereochemistry in bioequivalence studies of chiral drugs is discussed.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.